Dr. Farah Abdel Rahman

Postdoctoral Research Fellow
School of Arts & Sciences – Natural Sciences

Dr. Farah Abdel Rahman obtained her a B.Sc in Biology, Teaching diploma in Science education and Master degree in Physiology at the American University of Beirut. There, she investigated the role of Nitric oxide and Epidermal growth factor receptor in mechanical stretch induced vascular remodeling in an Ex vivo culture model. After that, she received a PhD scholarship to the medical life science technology program at the Technical University of Munich (TUM) in Germany. As a PhD, she established a cell culture model to simulate systemic inflammation. Additionally, she investigated the role sphingosine-1-Phosphate (S1P) as a potential therapeutic agent during sepsis in a mouse model of LPS- induced endotoxemia (Journal of Thrombosis and Haemostasis,2020). Besides, she served on a multidisciplinary research team that succeeded in treating Duchenne muscular dystrophy (DMD) in a preclinical study using adeno associated virus carrying Cas-9 guide RNA (Nature Medicine, 2020). 

She was appointed as a postdoctoral fellow and an instructor at  the department of natural science at LAU in September 2020. Dr. Abdel Rahman will be utilizing state-of-the-art genomic technologies to better understand and diagnose genetic disorders. With the advent of next generation sequencing, she will analyze high throughput data to identify genetic variants of clinical interest as well as potential biomarkers and drug targets of disease among the Lebanese population.

Dr. Abdel Rahman is a recipient of the PhD scholarship award to the medical life science technology program.

Publications

  1. Abdel Rahman, F., et al., Sphingosine 1-phosphate attenuates LPS induced pericyte loss via activation of Rho-A and MRTF-A. Thrombosis and Haemostasis, 2020.
  2. Moretti, A., et al., Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Nat Med, 2020.
  3. Ziegler, T., et al., Atherosclerosis and the Capillary Network; Pathophysiology and Potential Therapeutic Strategies. Cells, 2019. 9(1).